Ignite Creation Date:
2025-12-25 @ 2:53 AM
Ignite Modification Date:
2025-12-26 @ 1:34 AM
Study NCT ID:
NCT04566133
Status:
TERMINATED
Last Update Posted:
2023-08-21
First Post:
2020-09-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions: